Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vectura appoints Neil Warner non-executive director and chair of audit committee

This article was originally published in Scrip

Executive Summary

Vectura Group, a UK-based company developing inhaled therapies for the treatment of respiratory diseases, has elected Neil Warner non-executive director and chair of the audit committee, effective 1 February. Mr Warner replaces Dr John Brown as chair of the audit committee; he will remain as Vectura's senior independent director and chair of the nomination committee. Mr Warner was finance director of Chloride Group for almost 14 years, and is the senior independent director and chair of the audit committee of Dechra Pharmaceuticals.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC011578

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel